PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors
PreveCeutical Announces Extension of Non-Brokered Private Placement
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
PreveCeutical Announces Non-Brokered Private Placement
PreveCeutical Adopts Semi-Annual Financial Reporting
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV)
PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement
PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics
BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer
BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research
PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting
PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer
PreveCeutical Announces Date for Annual General and Special Meeting
PreveCeutical Announces Non-Brokered Private Placement
PreveCeutical Welcomes Stephen Glover as Corporate Advisor
PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement
PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies
PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement
PreveCeutical Announces Up-Sized Non-Brokered Private Placement
PreveCeutical Announces Update to Non-Brokered Private Placement
PreveCeutical Announces Update to Private Placement
PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease
Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects
PreveCeutical Announces Non-Brokered Private Placement
BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference
PreveCeutical Announces Change of Auditors
BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors
BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board
BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors
BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors
BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board
PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer
PreveCeutical Announces Closing of BioGene Therapeutics Transaction
PreveCeutical's Subsidiary, BioGene Therapeutics, Appoints President
PreveCeutical Launches Strategic Partnership with BioGene Therapeutics
PreveCeutical Engages Phoenix Corporate Finance Inc. to Provide Advisory Services